Ballanger F, Baudry P, N'Guyen J M, Khammari A, Dréno B
Department of Dermatology, Hôtel-Dieu, FR-44035 Nantes, France.
Dermatology. 2006;212(2):145-9. doi: 10.1159/000090655.
The role of heredity in acne severity and therapeutic response remains unclear.
A prospective epidemiologic study was performed to compare clinical and evolutive features of acne and response to treatment in 151 patients with acne with (A+) or without (A-) family history of acne.
A+ and A- patients were compared on clinical and therapeutic criteria. A+ patients were then distributed into subgroups (M+, F+, M+F+) following the origin of family history (father: F, mother: M).
The clinical profile was similar in the A+ and A- populations. Acne occurred earlier and more often before puberty in the A+ population, in which oral treatments and relapse after isotretinoin were more frequent. Retentional lesions (number and extent) were more important in the M+ and M+F+ populations.
This study confirms the importance of heredity as a prognostic factor for acne. Family history of acne is associated with earlier occurrence of acne, increased number of retentional lesions and therapeutic difficulties.
遗传在痤疮严重程度和治疗反应中的作用仍不明确。
进行一项前瞻性流行病学研究,比较151例有(A+)或无(A-)痤疮家族史的痤疮患者的痤疮临床及演变特征和治疗反应。
根据临床和治疗标准对A+和A-患者进行比较。然后根据家族史来源(父亲:F,母亲:M)将A+患者分为亚组(M+、F+、M+F+)。
A+和A-人群的临床特征相似。A+人群中痤疮在青春期前出现得更早且更频繁,其中口服治疗及异维A酸治疗后的复发更常见。M+和M+F+人群中的潴留性损害(数量和范围)更严重。
本研究证实遗传作为痤疮预后因素的重要性。痤疮家族史与痤疮更早发生、潴留性损害数量增加及治疗困难相关。